Odyssey Therapeutics
Odyssey Therapeutics is a biotechnology company focused on developing next-generation immunomodulators and oncology drugs. By leveraging an integrated drug-hunting engine, the company aims to enhance the efficiency of drug discovery, identifying promising targets while reducing the likelihood of failure during development. Odyssey Therapeutics is committed to advancing the field of drug discovery and expediting clinical development, ultimately contributing to the creation of more effective precision medicines for the healthcare industry.
Rahko Limited is a company specializing in quantum machine learning (QML) software for chemical simulation, headquartered in London, United Kingdom. Founded in 2018, Rahko develops a platform that offers advanced QML algorithms and tools to enhance accessibility to quantum computers. The platform is designed to address significant challenges in chemical simulations relevant to batteries, chemicals, materials, and pharmaceuticals. By collaborating with major quantum hardware manufacturers and large corporations, Rahko aims to solve practical, commercially valuable problems within the realm of quantum chemistry. Their team consists of experts in various fields, including quantum software engineering and quantum chemistry, enabling them to make substantial progress in unlocking the potential of quantum technologies for scientific and industrial applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.